(Total Views: 1520)
Posted On: 05/25/2020 5:44:57 PM
Post# of 151807
RA Capital Covid-19 Analyse
Who we are:
RA Capital funds and builds healthcare and life science companies
https://www.racap.com/covid-19
Therapeutics (Cytodyn in green rectangle and looks like a frontrunner):
There are not so many alternatives anymore, after the hydroxychloroquine (suspended from trials) and remdesevir (no significant results or improvements), especially without side effects (eidd 2801 and all oral medicine) it gets very dark and scaling is not that easy (mesoblast)!
Overall analysis:
https://www.racap.com/media/Covid-19/COVID-19...hXAIx6ImKk
Who we are:
RA Capital funds and builds healthcare and life science companies
https://www.racap.com/covid-19
Therapeutics (Cytodyn in green rectangle and looks like a frontrunner):
There are not so many alternatives anymore, after the hydroxychloroquine (suspended from trials) and remdesevir (no significant results or improvements), especially without side effects (eidd 2801 and all oral medicine) it gets very dark and scaling is not that easy (mesoblast)!
Overall analysis:
https://www.racap.com/media/Covid-19/COVID-19...hXAIx6ImKk
(1)
(0)Scroll down for more posts ▼
